Areas of Focus
- Integrating various omics data to analyze the impact of Y chromosome loss on cancer and clonal hematopoiesis
- Analyzing molecular mechanisms of gender differences in cancer using genomic and transcriptomic data
- Exploring new cancer treatment strategies and drug development
- Developing computational methods for chromosome variation analysis using next-generation sequencing and single-cell sequencing
Work Experience
- 2024-01 to Present - Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences - Researcher
- 2019-08 to 2023-11 - Massachusetts General Hospital, Harvard Medical School - Postdoctoral Researcher
Academic Background & Achievements
- 2013-09 to 2019-01 PhD in Genetics: University of Chinese Academy of Sciences
- 2009-09 to 2013-07 Bachelor's in Life Sciences: East China University of Science and Technology
Publications
- Loss of chromosome Y in primary tumors, Meifang Qi, 2023
- Genomics of PDGFR-rearranged hypereosinophilic syndrome, Meifang Qi, 2023
- cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries, Meifang Qi, 2021
- Plant Regulomics: a data-driven interface for retrieving upstream regulators from plant multi-omics data, Meifang Qi, 2020
- Polycomb repressive complex 2 attenuates ABA-induced senescence in Arabidopsis, Meifang Qi, 2019
- CGT-seq: epigenome-guided de novo assembly of the core genome for divergent populations with large genome, Meifang Qi, 2018
- GSHR, a Web-Based Platform Provides Gene Set-Level Analyses of Hormone Responses in Arabidopsis, Meifang Qi, 2018
- Divergent regeneration‐competent cells adopt a common mechanism for callus initiation in angiosperms, Meifang Qi, 2017
- CARMO: a comprehensive annotation platform for functional exploration of rice multi-omics data, Meifang Qi, 2015
Awards
- Patent (2023): Low-cost assembly and analysis of core genome information based on epigenomic information, 2nd author, Patent No: CN110317856B